Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Updates throughout, adding quotes, background, details)By Kate KellandLONDON, March 3 (Reuters) - British scientists urged European countries to take note on Wednesday of interim data showing what they described as "remarkable" effectiveness of a ...
Read moreBy Francesco Guarascio and Ludwig BurgerBRUSSELS, March 3 (Reuters) - The European Union drug regulator does not see enough evidence yet to recommend changes to the dosage regime for COVID-19 vaccines, despite pressure from EU states after positiv...
Read moreMILAN, March 3 (Reuters) - Some Italian companies have given their availability to produce COVID-19 vaccines and the production could take off in 4-6 months after regulators' authorisation, the industry ministry said on Wednesday.Many companies wo...
Read moreLONDON, March 3 (Reuters) - One dose of either Pfizer-BioNTech's or AstraZeneca's COVID-19 vaccine helps to prevent disease severe enough to require hospitalisation of people in their 80s with other illnesses, interim data from a UK study showed ...
Read more(Adds details, background)BERLIN, March 3 (Reuters) - Germany's vaccine regulator should recommend within days that the AstraZeneca coronavirus vaccine can be given to people older than 65 as evidence mounts of its efficacy, Health Minister Jens S...
Read more
TOP NEWS: US court finds in AstraZeneca's favour in patent litigation
Read more
(Sharecast News) - A US court has ruled in favour of AstraZeneca in patent litigation concerning asthma treatment Symbicort, the Anglo-Swedish drugs firm said on Wednesday.
Read more(Adds AstraZeneca statement)By Sangmi ChaSEOUL, March 3 (Reuters) - South Korean authorities are investigating the deaths of two people, both with pre-existing conditions, who died within days of receiving AstraZeneca's COVID-19 vaccine.AstraZenec...
Read moreNEW DELHI, March 3 (Reuters) - Government ministers and officials were following Prime Minister Narendra Modi lead by opting on Tuesday for an Indian-made COVID-19 vaccine approved without late-stage efficacy data, instead of the AstraZeneca one....
Read moreBERLIN, March 3 (Reuters) - Germany's vaccine regulator should recommend within days that AstraZeneca coronavirus vaccines can be given to people older than 65 as evidence mounts of their efficacy, Health Minister Jens Spahn said on Wednesday.Data...
Read moreMILAN, March 3 (Reuters) - The European Union aims to increase the region's COVID-19 vaccine production capacity to 2-3 billion doses per year by the end of 2021, Industry Commissioner Thierry Breton was quoted as saying on Wednesday.In an intervi...
Read more(Adds comments by CEO of pharmaceutical company)BRASILIA, March 2 (Reuters) - Brazilian state governors scrambling to secure COVID-19 vaccines said on Tuesday they are getting together to bypass President Jair Bolsonaro's government and buy shots ...
Read more(Adds comments from MSF, Emergency)By Bhargav AcharyaMarch 2 (Reuters) - The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said on Tuesday.SII, the world's largest vaccin...
Read more(Recasts with UK government statement, adds background)By Bhargav AcharyaMarch 2 (Reuters) - The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said in a statement on Tue...
Read moreMarch 2 (Reuters) - The UK will receive its first tranche of 10 million Indian-made Oxford-AstraZeneca COVID-19 vaccine doses next week, Politico reported on Tuesday, citing UK officials."The U.K. has ordered 100 million doses of AstraZeneca's COV...
Read more
Last checked at